Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes

[1]  J Zhang,et al.  Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes , 2021, Scientific Reports.

[2]  J Zhang,et al.  Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end‐stage renal disease , 2020, Journal of diabetes.

[3]  Lijun Zhao,et al.  Associations Between High-Altitude Residence and End-Stage Kidney Disease in Chinese Patients with Type 2 Diabetes. , 2020, High altitude medicine & biology.

[4]  J Zhang,et al.  Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients , 2020, International journal of medical sciences.

[5]  M. Tsai,et al.  Addition of Metabolic Syndrome to Albuminuria Provides a New Risk Stratification Model for Diabetic Kidney Disease Progression in Elderly Patients , 2020, Scientific Reports.

[6]  A. Sinclair,et al.  Diabetes and global ageing among 65-99-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2020, Diabetes research and clinical practice.

[7]  J Zhang,et al.  DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  Lijun Zhao,et al.  Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus , 2020, Renal failure.

[9]  L. Lerman,et al.  Coexisting renal artery stenosis and metabolic syndrome magnifies mitochondrial damage, aggravating poststenotic kidney injury in pigs. , 2019, Journal of hypertension.

[10]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[11]  H. Shih,et al.  Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes. , 2019, Diabetes research and clinical practice.

[12]  Lijun Zhao,et al.  Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome , 2019, Acta Diabetologica.

[13]  Fang Liu,et al.  The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy , 2019, Journal of diabetes research.

[14]  A. Motala,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition , 2019 .

[15]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[16]  S. Eiam‐Ong,et al.  The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study , 2018, PloS one.

[17]  P. Scherer,et al.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease , 2018, Nature Reviews Nephrology.

[18]  G. Paré,et al.  HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  Mei-yu Cui,et al.  Association between metabolic syndrome and chronic kidney disease in a Chinese urban population. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[20]  L. Lerman,et al.  The metabolic syndrome induces early changes in the swine renal medullary mitochondria , 2017, Translational research : the journal of laboratory and clinical medicine.

[21]  Rui Zhang,et al.  Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice* , 2016, The Journal of Biological Chemistry.

[22]  J. Coresh,et al.  Trends in Chronic Kidney Disease in China. , 2016, The New England journal of medicine.

[23]  Lin Sun,et al.  Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China. , 2016, Journal of diabetes and its complications.

[24]  Jia-Jung Lee,et al.  Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease , 2016, Scientific Reports.

[25]  N. Vaziri.  HDL abnormalities in nephrotic syndrome and chronic kidney disease , 2016, Nature Reviews Nephrology.

[26]  R. Bonofiglio,et al.  Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage , 2016, Journal of Nephrology.

[27]  N. Nakamura,et al.  Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study , 2015, Endocrine.

[28]  L. Lerman,et al.  Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease. , 2013, American journal of physiology. Renal physiology.

[29]  S. Kashyap,et al.  Metabolic syndrome and kidney disease: a systematic review and meta-analysis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[30]  Jai Radhakrishnan,et al.  Pathologic classification of diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[31]  Z. Varghese,et al.  An update on the lipid nephrotoxicity hypothesis , 2009, Nature Reviews Nephrology.

[32]  G. Hitman,et al.  Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[34]  Ajay K. Singh,et al.  Kidney pathological changes in metabolic syndrome: a cross-sectional study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Xilin Yang,et al.  Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes , 2008, Diabetes Care.

[36]  J. Axelsson,et al.  Waist circumference and visceral fat in CKD: a cross-sectional study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  I. Okpechi,et al.  Microalbuminuria and the metabolic syndrome in non-diabetic black Africans , 2007, Diabetes & vascular disease research.

[38]  T. van der Poll,et al.  High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[39]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[40]  G. Marchesini,et al.  WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[41]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[42]  A. Eddy,et al.  Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. , 1998, Kidney international.

[43]  P. Ratcliffe,et al.  The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. , 1997, Kidney international.